4,6-O-Benzylidene-N-(tBoc)-2-O-(4-toluenesulfonyl)-1,5-imino-D-glucitol

4,6-O-Benzylidene-N-(tBoc)-2-O-(4-toluenesulfonyl)-1,5-imino-D-glucitol, a derivative of the iminosugar 1-deoxynojirimycin (DNJ), is extensively employed in research for its inhibitory properties against glycosidases. By acting as a mimic of the transition state of glycosidase-catalyzed reactions, this compound functions as a potent glycosidase inhibitor. Specifically, the benzylidene group at the 4,6-position enhances its binding affinity to the active site of glycosidases, thereby obstructing substrate access and inhibiting enzyme activity. Moreover, the N-tert-butoxycarbonyl (tBoc) and 4-toluenesulfonyl (Ts) protecting groups ensure the stability and selectivity of the compound during synthesis and experimentation. In research, this chemical is utilized to probe the mechanisms of glycosidase enzymes, explain carbohydrate metabolism pathways, and investigate the roles of glycosidases in various biological processes. Furthermore, it serves as a valuable tool in drug discovery efforts targeting glycosidase-related diseases such as lysosomal storage disorders, viral infections, and cancer. The compound′s unique structural features and inhibitory properties make it indispensable for studying carbohydrate processing enzymes and developing novel interventions against glycosidase-associated disorders.